课题基金 / 基金详情

Tenascin-C参与肺成纤维细胞功能调控在慢阻肺气道重塑机制中的作用

批准号:
82100053
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
郝斌威
依托单位:
学科分类:
慢性阻塞性肺疾病
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
郝斌威

项目摘要

结项摘要

相似基金

相关文献

中文摘要
小气道重塑是慢性阻塞性肺疾病的主要病理改变,肺成纤维细胞异常激活致细胞外基质(ECM)过多沉积是外周小气道重塑的主要原因。近年来发现ECM分子基质蛋白Tenascin-C (TNC)具有生物活性,参与慢阻肺气道重塑,但具体机制不详。申请人前期研究显示,慢阻肺患者血清TNC表达增加,且与疾病严重程度正相关,体外重组TNC可诱导成纤维细胞分泌和迁移能力增加。最新研究表明TNC可激活TLR4受体参与某些慢性疾病的发生发展。因此,推测TNC可影响成纤维细胞功能障碍而参与慢阻肺气道重塑过程。本研究从细胞、组织、整体等多个水平,利用siRNA等多种技术手段,探讨ECM/TNC通过激活TLR4或整合素αvβ3、α2β1等分子机制,触发成纤维细胞增殖、分泌和迁移等细胞生物学功能,最终引起气道重塑的病理生理改变,为进一步阐明慢阻肺气道重塑机制和寻找新的治疗靶点提供科学的实验依据。
英文摘要
Small airway remodeling is a crucial pathological change in chronic obstructive pulmonary disease (COPD), excessive deposition of extracellular matrix (ECM) caused by abnormal activation of lung fibroblasts is the main cause of peripheral airways remodeling. It has been recently considered that the matrix protein tenascin-C (TNC), as a biologically active ECM protein molecules, participated in airway remodeling of COPD, but the mechanism is unknown. Our previous studies showed that the elevated TNC in serum of patients with COPD was positively correlated with the severity of the disease, and recombinant human TNC induced the increased secretion and migration of fibroblasts. TNC participated in the development of certain chronic diseases through activate TLR4 receptors in the latest research. Therefore, we propose that the dysfunction of fibroblast induced by TNC plays a key role in the airway remodeling process of COPD. The effect of ECM/TNC on the function of fibroblast in airway remodeling is to be investigated in fibroblast, animal model and patients of COPD. In this study, using the technology of TNC knockdown including RNA interference, we attempted to explored that the role and mechanism of ECM/TNC involved in the proliferation, secretion, and migration of fibroblast via the activation of the pathway of TLR4 or integrin receptor αvβ3 and α2β1, which eventually leading to pathophysiological changes of airway remodeling in COPD. The data will to provide fundamental scientific basis for further elucidating the mechanism of airway remodeling and developing the new therapeutic target of COPD.
气道重塑是慢阻肺主要的病理特征,是慢阻肺持续气流受限的主要原因。气道成纤维细胞功能障碍分泌更多细胞外基质是气道重塑的一个主要机制。研究证实TGF-β可刺激成纤维细胞增值、分泌增多等,参与慢阻肺的发生发展。本课题将深入研究:基质蛋白Tenascin-C(TNC)在慢阻肺患者中及烟草烟雾或生物燃料导致小鼠/大鼠肺气肿模型中的表达;以及探索Tenascin-C和转化生长因子(TGF-β)对成纤维细胞功能障碍的相关机制。我们研究显示:1)相比对照组,慢阻肺患者血清TNC及TGF-β1水平明显升高,且其表达与慢阻肺严重程度呈正相关,血清TNC及TGF-β1水平成正相关;2)生物燃料可导致大鼠慢阻肺发生,且TNC及TGF-β1表达明显升高,且呈正相关;TNC敲除可缓解烟草烟雾暴露导致小鼠肺功能下降及肺气肿发生;提示血清TNC及TGF-β1可能参与慢阻肺的发生发展。3)TGF-β1可诱导成纤维细胞TNC的表达增多;TNC敲低可通过SMAD3通路抑制TGF-β1可诱导成纤维细胞分泌细胞外基质的表达TNC可能为慢阻肺治疗提供新的靶点。
国内基金
海外基金